Correction to: Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives (Naunyn-Schmiedeberg's Archives of Pharmacology, (2023), 396, 2, (191-212), 10.1007/s00210-022-02298-0)

Hardeep Singh Tuli, Vivek Kumar Garg, Ajay Kumar, Diwakar Aggarwal, Uttpal Anand, Nidarshana Chaturvedi Parashar, Adesh K. Saini, Ranjan K. Mohapatra, Kuldeep Dhama, Manoj Kumar, Tejveer Singh, Jagjit Kaur, Katrin Sak

Research output: Contribution to journalComment/debate

Abstract

The original article contains incorrect affiliation (Ben-Gurion University of the Negev, 8499000, Midreshet Ben Gurion, Israel) of co-author, Anand Uttpal. At the time of submission of this article, the correct affiliation of co-author, Anand Uttpal was CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.– Barabanki, 225001, Uttar Pradesh, India The authors apologize for this error.

Original languageEnglish
Pages (from-to)4475
Number of pages1
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume397
Issue number6
DOIs
StatePublished - 1 Jun 2024
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Correction to: Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives (Naunyn-Schmiedeberg's Archives of Pharmacology, (2023), 396, 2, (191-212), 10.1007/s00210-022-02298-0)'. Together they form a unique fingerprint.

Cite this